Clinical Research Informatics: Contributions from 2022.

OBJECTIVES

To summarize key contributions to current research in the field of Clinical Research Informatics (CRI) and to select best papers published in 2022.

METHOD

A bibliographic search using a combination of Medical Subject Headings (MeSH) descriptors and free-text terms on CRI was performed using PubMed, followed by a double-blind review in order to select a list of candidate best papers to be then peer-reviewed by external reviewers. After peer-review ranking, a consensus meeting between the two section editors and the editorial team was organized to finally conclude on the selected three best papers.

RESULTS

Among the 1,324 papers returned by the search, published in 2022, that were in the scope of the various areas of CRI, the full review process selected four best papers. The first best paper describes the process undertaken in Germany, under the national Medical Informatics Initiative, to define a process and to gain multi-decision-maker acceptance of broad consent for the reuse of health data for research whilst remaining compliant with the European General Data Protection Regulation. The authors of the second-best paper present a federated architecture for the conduct of clinical trial feasibility queries that utilizes HL7 Fast Healthcare Interoperability Resources and an HL7 standard query representation. The third best paper aligns with the overall theme of this Yearbook, the inclusivity of potential participants in clinical trials, with recommendations to ensure greater equity. The fourth proposes a multi-modal modelling approach for large scale phenotyping from electronic health record information. This year's survey paper has also examined equity, along with data bias, and found that the relevant publications in 2022 have focused almost exclusively on the issue of bias in Artificial Intelligence (AI).

CONCLUSIONS

The literature relevant to CRI in 2022 has largely been dominated by publications that seek to maximise the reusability of wide scale and representative electronic health record information for research, either as big data for distributed analysis or as a source of information from which to identify suitable patients accurately and equitably for invitation to participate in clinical trials.